Search Results 11-20 of 16867 for hla genotype

  1. A Study Of CSF-1R Inhibitor, AXatilimab For GVHD After HLA-matched Related And Unrelated Donor Allogeneic Stem Cell Transplantation (ABRAXAS) - Mayo Clinic

    This study will determine if axatilimab in combination with standard of care posttransplant cyclophosphamide+ tacrolimus/mycophenolate mofetil is safe, ...

  2. A Study Of NT-112 In HLA-C*08:02-Positive Adult Subjects With Unresectable, Advanced, And/ Or Metastatic Solid Tumors Positive For The KRAS G12D Mutation - Mayo Clinic

    A Study Of NT-112 In HLA-C*08:02-Positive Adult Subjects With Unresectable, Advanced, And/ Or Metastatic Solid Tumors Positive For The KRAS G12D Mutation · Share ...

  3. Chella S. David, Ph.D. - Mayo Clinic Faculty Profiles

    SUMMARY. Immunogenetics. My research centers on immunogenetic aspects of immune response with emphasis on the major histocompatibility complex (MHC) HLA ...

  4. ... HLA CL I ABC TYPING HR,775,822.00, 300000178,HC ... GENOTYPE,402,#N/A,#N/A 300000401,HC GALT KNOWN ... HLA AG,794,#N/A,#N/A 300000611,HC FLT3 GENE ...

  5. Clinical Trial of Upfront Haploidentical or Unrelated Donor Bmt to Restore Normal Hematopoiesis in Aplastic Anemia

    ;B-Leader genotype for HLA-B mismatched donor;; Male over female for larger donor weight or donor weight if known;; Domestic donors over international donors ...

  6. HLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation With Post-Transplantation Cyclophosphamide - Mayo Clinic

    The purpose of this study is to look at the effectiveness of using a study drug called cyclophosphamide (PTCy) to prevent graft versus host disease (GVHD) in ...

  7. A Study Of NT-175 In Adult Subjects With Unresectable, Advanced, And/or Metastatic Solid Tumors That Are Positive For HLA-A*02:01 And The TP53 R175H Mutation - Mayo Clinic

    A Study Of NT-175 In Adult Subjects With Unresectable, Advanced, And/or Metastatic Solid Tumors That Are Positive For HLA-A*02:01 And The TP53 R175H ...

  8. Allogeneic Stem Cell Transplant Clinical Trials - Mayo Clinic Research

    Selection of Allogeneic Hematopoietic Cell Donors Based on KIR and HLA Genotypes Rochester, MN. The purpose of this study is to test whether adding certain ...

  9. Study of the Safety, Tolerability, Pharmacokinetics and Biomarker of DONQ52 in Celiac Disease Patients - Mayo Clinic

    5 genotype (HLA-DQA1*05 and HLA-DQB1*02) (homozygous or heterozygous) ... genotyping must submit a blood sample to determine whether an eligible HLA-DQ2.

  10. Genotype-Phenotype Correlation in Cardiovascular Disease - Mayo Clinic

    This research study is being done to help characterize cardiovascular disease and improve diagnostic tests. OBJECTIVES. To understand the pathogenesis, ...